Holen Sie sich die Stockscreener-App
1.20
0.00%
0.00
Handel nachbörslich:
1.20
Silo Pharma Inc Aktie (SILO) Neueste Nachrichten
Silo Pharma Acquires IP Assets in Strategic Agreement - The Globe and Mail
A warrant for up to 300,000 shares is Silo Pharma (SILO)'s payment for software assets. - Stock Titan
NVIDIA models join QwikAgents, which adds a second software option for AI assistants. - Stock Titan
Why Is Silo Pharma (NASDAQ:SILO) Moving Into Focus? - Kalkine Media
Silo Pharma Inc (NASDAQ: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - kalkine.com.au
Silo Pharma Highlights Patented Nose-To-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum - marketscreener.com
Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting Progress of PTSD Candidate SPC-15 - citybuzz -
Silo Pharma to Participate in IPAC-RS 2026 Nasal Innovation Forum as It Advances SPC-15 Development - Quiver Quantitative
A nasal PTSD treatment met specs for nine months - Stock Titan
Silo Pharma Stock Price Forecast. Should You Buy SILO? - StockInvest.us
Silo Pharma Inc (NYSE: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - Kalkine
Silo Pharma Inc (SILO) Peer Comparison – Compare with Others - Value Research
Silo Pharma Inc (SILO) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Silo Pharma Acquires Digital Assets via Stock Issuance - The Globe and Mail
Form 8K Silo Pharma Inc For: 19 August By Investing.com - Investing.com South Africa
Form 8K Silo Pharma Inc For: 19 August By Investing.com - Investing.com Nigeria
Silo Pharma Acquires Digital Assets via Stock Issuance - TipRanks
Form 8K Silo Pharma Inc For: 19 August By Investing.com - Investing.com Canada
Form 8K Silo Pharma Inc For: 19 August - Investing.com India
Form 8K Silo Pharma Inc For: 19 August By Investing.com - Investing.com UK
Silo Pharma Acquires Software and IP From Parkview Consulting for 165,000 Shares - TradingView
Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting - TradingView
Silo Pharma (SILO) grants 165K locked-up shares in tech deal - Stock Titan
Silo PharmaEnters Asset Purchase Agreement - Moomoo
SILO 8-K & SEC Filings - Yahoo Finance Australia
Silo Pharma receives Canadian patent allowance for SPC-15 drug By Investing.com - Investing.com Canada
Silo Pharma receives Canadian patent allowance for SPC-15 drug By Investing.com - Investing.com Australia
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment - manilatimes.net
Silo Pharma receives Canadian patent allowance for SPC-15 drug By Investing.com - Investing.com India
Silo Pharma Receives Notice of Allowance for Canadian Patent Application Covering Lead Asset Spc-15 Targeting Ptsd and Other Stress-Induced Psychiatric Disorders - marketscreener.com
Silo (SILO) Technical Check: Adds 1.95% to Close at $3.13; Range and Risk: the $2.97 to $3.29 Range Remains in Focus in the Current UpdateSuperTrend - Vinanet
Silo (SILO) Technical Check: Adds 1.95% to Close at $3.13; Range and Risk: the $2.97 to $3.29 Range Remains in Focus in the Current UpdateCommon Gap - dars.gov.et
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment - GlobeNewswire
Silo Pharma Shareholders Approve Major Share Authorization Expansion - TipRanks
Silo Pharma (SILO) holders approve lifting share cap from 6.7M - Stock Titan
Silo Pharma (SILO) Slips 0.62% to $3.20 as Shares Consolidate Between Key Technical LevelsStock Picks - Vinanet
Silo Pharma (SILO) trims cash burn, mitigates going-concern risk in Q2 2026 - Stock Titan
Silo Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Silo Pharma (SILO) investor group discloses 9.99% warrant-based ownership cap - Stock Titan
Wondering what's happening in today's pre-market session? - ChartMill
Silo Pharma receives European patent for SPC-15 PTSD treatment By Investing.com - Investing.com South Africa
Silo Pharma Granted European Patent Covering Novel PTSD Therapy - The Manila Times
Silo Pharma receives European patent for SPC-15 PTSD treatment - Investing.com India
Silo Pharma receives European patent for SPC-15 PTSD treatment By Investing.com - Investing.com Canada
Silo Pharma Announces European Patent Grant for SPC-15 PTSD Prevention Therapy - Quiver Quantitative
Silo Pharma Granted European Patent Covering Novel PTSD Therapy - GlobeNewswire
SILO Q4 2023 Earnings: EPS Misses Estimates, Stock Gains 1.2% Despite No RevenueEarnings Beat Streak - dars.gov.et
SILO Q4 2023 Earnings: Wider-than-Expected Loss of -$5.40 per Share Highlights Heavy Pre-Revenue InvestmentTax Rate Impact - vinanet.vn
Silo Pharma Inc (SILO) Stock News Today - TradingKey
SILO Forecast & Price Target - TradingKey
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):